hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)#846947ClinicalTrials.gov
• Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study#852985ClinicalTrials.gov
• A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma#855438ClinicalTrials.gov
• Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria#856595ClinicalTrials.gov
• Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy#858355ClinicalTrials.gov
• Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment#881570ClinicalTrials.gov
• Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection#899310ClinicalTrials.gov
• A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC#906306ClinicalTrials.gov
• A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers#853211ClinicalTrials.gov
• Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.#261490ClinicalTrials.gov
• Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.#368060NCBI PubMed Central
• Cost-effectiveness of nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in China: a modeling study with price threshold analysis.#371750NCBI PubMed Central
• Development and Validation of a Clinical Radiomics Nomogram for Predicting Early Recurrence After Microwave Ablation in Hepatocellular Carcinoma Patients With Type 2 Diabetes.#392770NCBI PubMed Central
• Factors associated with unmet psychological care needs and development of a Neuman systems model-based risk prediction model in patients with hepatocellular carcinoma.#402606NCBI PubMed Central
• Early Changes in the Neutrophil-to-Lymphocyte Ratio are Associated with Conversion Outcomes in Advanced Hepatocellular Carcinoma Treated with HAIC-Based Triple Therapy.#457400NCBI PubMed Central
• Genetically Proxied IL-6 Receptor Blockade and Cancer Risk: A Multi-Ancestry Drug-Target Mendelian Randomization Study of Hepatocellular Carcinoma and Colorectal Cancer#474700bioRxiv / medRxiv
• A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients#832975ClinicalTrials.gov
• Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.#857498ClinicalTrials.gov
• Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents#860061ClinicalTrials.gov
• Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC#871231ClinicalTrials.gov
• Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis#875171ClinicalTrials.gov
• Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)#893272ClinicalTrials.gov
• Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection#896355ClinicalTrials.gov
• Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”#19924DOAJ
• The role of SPP1 in evaluating the prognosis, immune infiltration, and drug sensitivity of hepatocellular carcinoma#123676PLOS
• AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma.#146145NCBI PubMed Central
• Correlation of pretreatment imaging features with lung shunt fraction in patients with large hepatocellular carcinoma (maximum diameter >8 cm) planned for (90)Y-SIRT.#199165NCBI PubMed Central
• Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)#383564ClinicalTrials.gov
• A hierarchical assembly pathway directs the unique subunit arrangement of TRiC/CCT#439898S-Space: Seoul National University
• <i>Streptomyces</i>-linked exercise gene networks orchestrate immune exclusion and determine immunotherapy response in hepatocellular carcinoma#473114PLOS
• Elucidating the beneficial effects of gut microbiota-derived metabolites in treating hepatocellular carcinoma: an integrated network pharmacology, molecular docking, and single-cell sequencing analysis.#823560NCBI PubMed Central
• TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC#868195ClinicalTrials.gov
• PENS or TENS for Pain in Liver Cancer#881177ClinicalTrials.gov
• Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients#882473ClinicalTrials.gov
• A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma#895427ClinicalTrials.gov
• Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients#901333ClinicalTrials.gov
• Therasphere for Unresectable Primary or Secondary Liver Neoplasia#911242ClinicalTrials.gov
• ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort#801877ClinicalTrials.gov
• Impact of SETD8/KMT5A overexpression on hepatocellular carcinoma progression and prognosis#10233PLOS
• Identifying gene regulation modules associated with tumor metastasis using a network decomposition approach and combinatorial fusion analysis#316310PLOS
• Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma#340172IRIS
• Development and validation of a Random Forest prediction model integrating clinical and ultrasound radiomics features for microvascular invasion in hepatocellular carcinoma patients: a retrospective study.#368077NCBI PubMed Central
• Radioenhancing Hafnium Oxide Nanoparticles (NBTXR3) Followed by Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Liver Metastases (NBTXR3-103): Phase 1 Dose-Escalation Trial#370725HAL (France)
• Explainable machine learning and multimodal single cell analysis link NR4A2 to CD8(+) T-cell terminal exhaustion and a CD8-adjusted prognostic signature in hepatocellular carcinoma.#423024NCBI PubMed Central
• Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients#658223Dbt
• First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer#803919ClinicalTrials.gov
• Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer#828147ClinicalTrials.gov
• Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)#835937ClinicalTrials.gov
• Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies#855205ClinicalTrials.gov
• Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy#855235ClinicalTrials.gov